Condition
MIGS
Total Trials
4
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting2
Unknown1
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07073937Enrolling By Invitation
Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty
NCT06909058Not ApplicableActive Not Recruiting
Postoperative Restrictions for Patients Undergoing Minimally Invasive Gynecologic Procedures
NCT05035394Not ApplicableActive Not Recruiting
Swedish Microinvasive Glaucoma Surgery Study (SMIGS)
NCT05062668Unknown
Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma
Showing all 4 trials